NCT01491555|Completed
Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy
QED
Loading search results
QED
Sponsor study identifier
observational
73
1 country
1
Study Start
April 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2015
Actual (reported)Study Completion
September 2015
Actual (reported)Researchers at Children's Hospital Boston Neurology Department invite children to participate in a new research study. Researchers are looking for boys ages 2 - 30 with Duchenne Muscular Dystrophy (DMD) and healthy boys ages 2 - 30 (without any nerve or muscle concerns) to serve as controls. The study is evaluating a new technique that will test nerve and muscle function. The testing is all pain free. Children participating in the study will come in for 10 visits over two years. Visits will take place every month at first, then less often for the remaining visits. The tests for the study itself take approximately 2hours. If participants are interested or would like to learn more about the study, please call Lavanya Madabusi at 617-919-3554 or Lavanya.Madabusi@childrens.harvard.edu. All inquiries will be kept strictly confidential.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2015
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 5, 2011
Actual (reported)December 14, 2011
Actual (reported)April 2012
Date type not reportedThis date has not been verified as actual or estimated.
September 2015
Actual (reported)September 2015
Actual (reported)The rate of decline of DMD patients versus normal subjects as assessed by EIM and quantitative ultrasound
With the successful completion of this aim, the investigators will establish that alterations in both EIM and QUS provide meaningful surrogate measures of disease progression in DMD.
up to 45 months
The rate of decline of DMD patients versus normal subjects as assessed by handheld dynamometry, 6-minute walk, and other functional tests.
up to 45 months
35 boys ages 2 through 30 with DMD
35 healthy boys ages 2 through 30
This study will involve boys with DMD and healthy male controls.
Children's Hospital Boston
Boston, Massachusetts, 02115, United States
Basil Darras, MD
Boston Children's Hospital
Seward Rutkove, MD
Beth Israel Deaconess Medical Center
73 participants (actual enrollment reported by the registry).
First Submitted
December 5, 2011
First Posted
December 14, 2011
Study Start
April 2012
Date type not reportedThis date has not been verified as actual or estimated.
Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy
Contact the study team to confirm eligibility.
Primary Completion
September 2015
Actual (reported)Study Completion
September 2015
Actual (reported)Last Updated
March 24, 2016
Record last verified: 2016-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: